methyl 5-aminolevulinate has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YK; Cheng, KH; Chi, TC; Hu, CS; Huang, WL; Wang, YM; Wang, YY; Xiao, LY; Yuan, SF | 1 |
| Calin, MA; Calin, MR; Neagu, M; Petrescu, E | 1 |
2 other study(ies) available for methyl 5-aminolevulinate and Cancer of Mouth
| Article | Year |
|---|---|
MAL-PDT inhibits oral precancerous cells and lesions via autophagic cell death.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminolevulinic Acid; Animals; Autophagosomes; Autophagy; Body Weight; Cell Line, Tumor; Cell Survival; Cricetinae; Humans; Male; Microtubule-Associated Proteins; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Sequestosome-1 Protein; Signal Transduction; Tumor Burden | 2019 |
Increased number of fractionated irradiation sessions does not improve the cellular response to methyl aminolevulinate-mediated photodynamic therapy.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Humans; Mouth Neoplasms; Photochemotherapy; Radiotherapy Dosage; Treatment Outcome | 2013 |